Note: Ingredients listed on restricted chemical lists
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
EC/CAS
101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
N/A
EC/CAS
64742-46-7
Name of the chemical
Distillates (petroleum), hydrotreated middle
Concentration
N/A
EC/CAS
26447-40-5
Name of the chemical
Methylenediphenyl diisocyanate (see also specific isomers)
Concentration
N/A
EC/CAS
9016-87-9
Name of the chemical
4,4'-Methylendiphenyldiisocyanat tech. (Polymeres) MDI, pMDI (in Form atembarer Aerosole, A-Fraktion)
Concentration
N/A
General Information
Revision date
2015-05-15
Product name
AP Adhesive
Product Synonyms
AP ADHESIVE™
Icons in SDS
Company Information
company name
Dryvit Systems Canada
e-mail address of the competent person responsible for the Safety Data Sheet
ehs@dryvit.com
Section 2
SECTION 2: Hazards identification
Emergency overview WARNING: CONTAINS DIPHENYLMETHANE DIISOCYANATE (CAS No. 101-68-8). INHALATION OF MDI MISTS OR VAPORS MAY CAUSE RESPIRATORY IRRITATION, BREATHLESSNESS, CHEST DISCOMFORT AND REDUCED PULMONARY FUNCTION. OVEREXPOSURE WELL ABOVE THE PEL MAY RESULT IN BRONCHITIS, BRONCHIAL SPASMS AND PULMONARY EDEMA. LONG-TERM EXPOSURE TO ISOCYANATES HAS BEEN HAS BEEN REPORTED TO CAUSE LUNG DAMAGE, INCLUDING REDUCED LUNG FUNCTION WHICH MAY BE PERMANENT. ACUTE OR CHRONIC OVEREXPOSURE TO ISOCYANATES MAY CAUSE SENSITIZATION IN SOME INDIVIDUALS, RESULTING IN ALLERGIC RESPIRATORY REACTIONS INCLUDING WHEEZING, SHORTNESS OF BREATH AND DIFFICULTY BREATHING. MAY CAUSE EYE, SKIN AND RESPIRATORY TRACT IRRITATION. State of matter: solid Colour: tan Odour: oily
Principle Routes of Exposure
Routes of entry for solids and liquids include eye and skin contact, ingestion and inhalation. for gases include inhalation and eye contact. Skin contact may be a route of entry for liquified gases. Acute toxicity: May cause sensitization by inhalation. Irritation / corrosion: Irritating to eyes, respiratory system and skin. Sensitization: Sensitization after skin contact possible. The substance may cause sensitization of the respiratory tract. Studies in animals suggest that dermal exposure may lead to pulmonary sensitization. However, the relevance of this result for humans is unclear. Signs and symptoms of overexposure: In sensitized individuals, sensitization reactions may be elicited by structurally similar substances. Respiratory sensitization may result in allergic (asthma-like) signs in the lower respiratory tract including wheezing, shortness of breath and difficulty breathing, the onset of which may be delayed. Repeated inhalation of high concentrations may cause lung damage, including reduced lung function, which may be permanent. Substances eliciting lower respiratory tract irritation may worsen the asthma-like reactions that may be produced by product exposures.